Comparison of Dexmedetomidine + Ketamine for Postoperative Pain in C-Section
Launched by FATIMA MEMORIAL HOSPITAL · Jun 7, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well different doses of a medication called dexmedetomidine, paired with a set amount of another medication called ketamine, can help control pain after a cesarean section (C-section). The main goal is to find the best combination that provides effective pain relief while causing the fewest side effects for women who have undergone this surgery.
To participate in this study, women aged 18 to 62 who are scheduled for an elective C-section and meet specific health criteria may be eligible. Participants will receive one of the different doses of dexmedetomidine along with ketamine to see how well it works for pain management. It's important to note that individuals with certain health issues or allergies, or those needing emergency surgery, will not be included in this trial. If you or someone you know is interested, this study is currently recruiting participants.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Elective lower segment cesarean section
- • American Society of Anesthesiologists (ASA) Physical Status II
- • Provided informed consent
- Exclusion Criteria:
- • Known drug allergy
- • Presence of significant comorbidities
- • Emergency surgery
- • Documented psychiatric illness
About Fatima Memorial Hospital
Fatima Memorial Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to ethical standards and patient safety, the hospital provides a comprehensive infrastructure that supports a wide range of clinical studies across various medical disciplines. Collaborating with experienced researchers and healthcare professionals, Fatima Memorial Hospital aims to contribute to the development of new therapies and treatment protocols, ultimately enhancing health outcomes for the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported